Skip to main content
. 2019 Nov 20;9:17203. doi: 10.1038/s41598-019-53755-5

Figure 5.

Figure 5

Interaction of Varespladib and myristic acid (FA14) with side chain of residues from Helix-I, hydrophobic channel and MDiS residues. (A) Overall crystal structure of MjTX-II/Varespladib (cyan), zoomed region of contacts of inhibitor to side chain of aminoacids from protein and the same region after 90° of rotation. (B) Overall of crystal structure of MjTX-II/FA14 (green), zoomed region from the interaction of fatty acid molecule with the protein and the same region after 90° of rotation.